Jul 29 (Reuters)-
Genky Drugstores Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Jun 20, 2025 Jun 20, 2024 Jun 20, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 200.79 184.86 221.84 109.21
(+8.6 pct) (+9.3 pct) (+10.5 pct) (+10.6 pct)
Operating 9.66 9.02 10.50 5.27
(+7.1 pct) (+34.4 pct) (+8.7 pct) (+14.6 pct)
Recurring 9.90 9.27 10.70 5.36
(+6.8 pct) (+30.9 pct) (+8.1 pct) (+13.5 pct)
Net
Net 7.07 6.32 7.50 3.70
(+11.7 pct) (+32.7 pct) (+6.1 pct) (+13.2 pct)
EPS 232.51 yen 208.21 yen 246.74 yen 121.73 yen
EPS Diluted 232.04 yen 207.94 yen
Ann Div 13.00 yen 25.50 yen 13.00 yen
-Q2 Div 6.50 yen 12.50 yen 6.50 yen
-Q4 Div 6.50 yen 13.00 yen 6.50 yen
NOTE - Genky Drugstores Co., Ltd..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9267.T